We found 4 drugmaker programs for Thalassemia medicines and 2 charity funds (0 open at our last check). Tell us your insurance below and we'll show what to try first.
Help for Thalassemia depends mostly on how you're covered. Pick the one that sounds like you. We'll name the funds and programs that fit, and what won't work, so you don't waste a phone call.
Independent foundations pay copays, coinsurance and sometimes insurance premiums for people who already have coverage. Funds open and close as donations come in, so each one shows what the foundation said on the date we checked.
Covers: Travel to a major thalassemia treatment center for comprehensive care. Up to $500 a year.
Covers: Health-maintenance expenses (treatments, devices) for patients age 50 and older. Up to $500 a year.
Copay cards lower what people with private insurance pay. Federal rules bar them for Medicare, Medicaid and TRICARE. Free medicine programs are for people without enough coverage and usually have income limits. We read each program on the drugmaker's own site.
The AQVESME Copay Program lowers costs for eligible commercially insured patients to $0 per prescription, regardless of income. Not for Medicare, Medicaid, TRICARE or retiree plans.
Coverage Interruption Program for people whose insurance coverage is interrupted. People with government insurance are not eligible.
Patient Assistance Program for people who are uninsured or whose insurance (government or commercial) does not cover AQVESME.
A Patient Support Manager reviews your insurance, helps fill your prescription and works with your doctor.
The myAgios page does not state income limits or whether the Patient Assistance Program is free medicine; call myAgios for details. Government-insured patients may be referred to independent foundations.
A Care Manager answers questions, shares guides, and works with your treatment center on the logistics of your gene therapy.
Care Managers check whether you qualify for treatment-related travel and lodging assistance. Eligibility requirements apply.
Fertility support may be available for sickle cell patients insured by Medicaid in certain states, through the CMS Cell and Gene Therapy Access Model.
Enrollment is not required to receive CASGEVY. The official pages do not describe copay help or who qualifies for travel support. Call 1-833-VERTEX-5, Monday to Friday, 8 am to 8 pm ET.
BMS Access Support Co-Pay Assistance Program helps eligible commercially insured patients with co-pays or co-insurance for Reblozyl. Government insurance is not eligible.
Helps with benefits checks, prior authorizations and appeals, and refers patients to independent charitable foundations. Mon-Fri 8 AM-8 PM ET.
Reblozyl is marketed in the US by Bristol Myers Squibb (licensed from Merck). Medicare/Medicaid/TRICARE patients can't use the BMS co-pay program but may be referred to independent foundations. Ask BMS Access Support whether the BMS Patient Assistance Foundation covers Reblozyl.
A no-cost program with a dedicated Patient Navigator who helps with insurance and costs, finding a qualified treatment center that accepts your insurance and is taking new patients, and coordinating each stage of treatment.
Travel and accommodation assistance. Eligibility for support services is determined by Genetix.
Financial and logistical support for fertility preservation. Eligibility for support services is determined by Genetix.
bluebird bio renamed itself Genetix Biotherapeutics on September 18, 2025, and mybluebirdsupport.com now redirects to genetixcares.com; zynteglo.com still uses the my bluebird support name. The official pages do not describe a copay program or say who qualifies for travel or fertility support.
Most of these programs start with one call, and having these ready makes it shorter. Tick them off as you go. Nothing here is saved or sent anywhere.
Call the drugmaker's support line first. Its case managers check your benefits and often fill out forms with your doctor. If a charity fund is closed, sign up on the foundation's page to hear when it reopens. Most programs need renewing every year, and many copay cards reset in January.
Yes. Trial Friend lists 4 drugmaker programs for Thalassemia medicines and 2 charity funds, 0 of them open at our last check. We checked every one at the source on or before October 19, 2026. Which ones fit depends on your insurance. Copay cards are for people with private insurance, charity funds usually need some insurance, and free medicine programs are for people without enough coverage.
No. Federal rules bar drugmaker copay cards for drugs paid by Medicare, Medicaid or TRICARE. For Thalassemia, 0 charity funds on this page accept Medicare, and 0 drugmaker free medicine programs name Medicare patients among those who may qualify. In 2026, Medicare Part D also caps yearly out-of-pocket costs for covered drugs at $2,100.
None of the 2 funds listed for Thalassemia was open to new applicants at our last check. Funds reopen when new donations arrive, and each foundation lets you sign up to hear when one opens.
None of the drugmaker programs for Thalassemia medicines on this page says it gives free medicine to people without insurance. Their support lines can still check what you qualify for. Most charity funds need some insurance.
How we check: drugmaker programs come only from each drugmaker's own pages. Fund status is copied from each foundation's list (Cooley's Anemia Foundation) on the date shown. Programs change, so confirm with the program before you rely on it. Trial Friend shares information, not financial, legal or medical advice, and each program decides who qualifies. See something wrong? Email jason@trialfriend.com.
